Trial Profile
Adjuvant chemotherapy with gemcitabine versus observation in patients undergoing curative-intent resection of pancreatic cancer: a multicentre randomised controlled trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 May 2021
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 29 Apr 2021 Results of pooled analysis from three clinical studies: CONKO-001, CONKO-005, and CONKO-006 published in the European Journal of Cancer
- 31 May 2020 Results of a pooled analysis from four phase III trials: CONKO-001, JASPAC-01, ESPAC-4 and PRODIGE assessing prolongation of average survival time, prolongation of average event free time and time lived without an event presented at the 56th Annual Meeting of the American Society of Clinical Oncology
- 31 Mar 2020 Results published in the Clinical Cancer Research